Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EPS Growth

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year EPS Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EPS Growth(%) 169.73-605.16-68.44-2.9225.01

What is the latest EPS Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EPS Growth ratio of GLENMARK PHARMACEUTICALS is 169.73 based on Mar2025 Consolidated results.
Year EPS Growth
Mar2025169.73
Mar2024-605.16
Mar2023-68.44
Mar2022-2.92
Mar202125.01

How is EPS Growth of GLENMARK PHARMACEUTICALS Trending?

Years EPS Growth % Change
Mar2025 169.73
Positive
Mar2024 -605.16
Negative
Mar2023 -68.44
Negative
Mar2022 -2.92
Negative
Mar2021 25.01 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EPS Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,202.1 Cr 3.4% 6.4% 41.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.4%

6.4%

41.8%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses